Company record
Konrad Rejdak, M.D., Ph.D.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Konrad Rejdak, M.D., Ph.D..
Warning letters
-
BiologicsKonrad Rejdak, M.D., Ph.D.
FDA warns Dr. Konrad Rejdak over clinical trial data integrity failures in a CIDP immune globulin study.
Medium